- Home
- INKT vs SRXH Comparison
INKT vs SRXH Comparison
Compare INKT & SRXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- SRXH
- Stock Information
- Founded
- INKT 2017
- SRXH 2013
- Country
- INKT United States
- SRXH Canada
- Employees
- INKT N/A
- SRXH N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- SRXH
- Sector
- INKT Health Care
- SRXH
- Exchange
- INKT Nasdaq
- SRXH NYSE
- Market Cap
- INKT 31.2M
- SRXH 27.7M
- IPO Year
- INKT 2021
- SRXH N/A
- Fundamental
- Price
- INKT $7.14
- SRXH $0.63
- Analyst Decision
- INKT Strong Buy
- SRXH
- Analyst Count
- INKT 2
- SRXH 0
- Target Price
- INKT $37.50
- SRXH N/A
- AVG Volume (30 Days)
- INKT 5.5K
- SRXH 7.1M
- Earning Date
- INKT 05-15-2025
- SRXH 05-15-2025
- Dividend Yield
- INKT N/A
- SRXH N/A
- EPS Growth
- INKT N/A
- SRXH N/A
- EPS
- INKT N/A
- SRXH N/A
- Revenue
- INKT N/A
- SRXH $119,421,918.00
- Revenue This Year
- INKT N/A
- SRXH $26.28
- Revenue Next Year
- INKT N/A
- SRXH $25.00
- P/E Ratio
- INKT N/A
- SRXH N/A
- Revenue Growth
- INKT N/A
- SRXH 26.27
- 52 Week Low
- INKT $4.56
- SRXH $0.47
- 52 Week High
- INKT $13.79
- SRXH $6.80
- Technical
- Relative Strength Index (RSI)
- INKT 47.31
- SRXH N/A
- Support Level
- INKT $6.89
- SRXH N/A
- Resistance Level
- INKT $7.25
- SRXH N/A
- Average True Range (ATR)
- INKT 0.42
- SRXH 0.00
- MACD
- INKT 0.01
- SRXH 0.00
- Stochastic Oscillator
- INKT 39.70
- SRXH 0.00
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About SRXH SRX HEALTH SOLUTIONS INC
SRX HealthSolutions Inc is an integrated, Canadian healthcare service provider operating within the specialty healthcare industry. It has developed a collaborative specialty healthcare network (the SRx Network) that strategically positions SRx to achieve business objectives. The SRx Network is comprised of 29 specialty pharmacies, 40 infusion clinics and injection sites, four clinical trials sites, patient support programs (PSP), an allied health team and nursing services, and a wholly owned Health Canada-accredited pharmaceutical wholesale and distribution facility located in Mississauga, Ontario. The SRx Network extends across all 10 Canadian provinces, making it one of the accessible providers of comprehensive, integrated and customized specialty healthcare services in Canada.